Optiver Holding
ORGO icon

Optiver Holding’s Organogenesis Holdings ORGO Stock Holding History

Optiver Holding’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Sell
4
-672
-99% -$1.64K ﹤0.01% 2732
2026
Q1 		$1.6K Buy
676
+120
+22% +$416 ﹤0.01% 1937
2025
Q4 		$2.88K Sell
556
-636
-53% -$3.08K ﹤0.01% 1776
2025
Q3 		$5.03K Buy
+1,192
New +$5.54K ﹤0.01% 1732

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Optiver Holding's ORGO Position: Q2 2026 in Review

Optiver Holding reduced its Organogenesis Holdings (ORGO) stake by 99% in Q2 2026, selling an estimated $1.64K and leaving 4 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Optiver Holding first reported a position in ORGO in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.03K in Q3 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Optiver Holding held 4 shares of Organogenesis Holdings worth $10 as of Q2 2026.
  • Optiver Holding sold 672 Organogenesis Holdings shares in Q2 2026, an estimated $1.64K.
  • Organogenesis Holdings made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2732 holding.
  • Optiver Holding first reported a position in Organogenesis Holdings in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Organogenesis Holdings position peaked at $5.03K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.